TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.

Håland, Erling; Moen, Ingrid Nyhus; Veidal, Elias; Hella, Hanne; Misund, Kristine; Slørdahl, Tobias S; Starheim, Kristian K

Håland, Erling; Moen, Ingrid Nyhus; Veidal, Elias; Hella, Hanne; Misund, Kristine; Slørdahl, Tobias S; Starheim, Kristian K.

Afiliación

Håland E; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.
Moen IN; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.
Veidal E; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.
Hella H; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.
Misund K; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway.
Slørdahl TS; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.
Starheim KK; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.

Oncotarget ; 12(21): 2158-2168, 2021 Oct 12.

Article en En | MEDLINE | ID: mdl-34676048

Palabras clave

NF-κB; TAK1; apoptosis; cancer treatment; multiple myeloma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2021 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google